First clinical results for RMC-9805, a RAS(ON) G12D-selective inhibitor, demonstrate encouraging tolerability and antitumor activity in patients with PDAC Investor webcast to be held Friday, October ...
Get detailed information about the Galaxy Bosera MSCI China ASEAN Economic Linkage Se ETF. View the current 9805 stock price chart, historical data, premarket price, dividend returns and more.
Revolution Medicines, Inc. - (GLOBE NEWSWIRE) Oct 25, 2024 16 mins ago First clinical results for RMC-9805, a RAS (ON) G12D-selective inhibitor, demonstrate encouraging tolerability and antitumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results